FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 306:506-510 March 4, 1982 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We performed a double-blind, controlled study of prophylactic indomethacin therapy in 47 premature infants (less than 1700 g) who had subclinical patent ductus arteriosus. They received either indomethacin or placebo at a mean age of 2.9 days. Among the 25 infants weighing more than 1000 g, a hemodynamically important ductus shunt developed in only four of the 14 given placebo. The incidence of important shunts, the number of surgical ligations, and the duration of oxygen therapy were not appreciably different between the study groups. In contrast, among the 22 infants who weighed 1000 g or less, a major ductus shunt developed in 10 of the 12 given placebo. In the smaller infants indomethacin therapy was associated with a significantly lower incidence of major shunts, fewer surgical ligations, a decreased duration of oxygen therapy, and fewer days necessary to regain birth weight. We conclude that prophylactic indomethacin therapy in infants weighing under 1000 g prevents the later development of large ductus shunts and decreases morbidity.

This article has been cited by other articles:

• Gien, J. (2008). Controversies in the Management of Patent Ductus Arteriosus. NeoReviews 9: e477-e482 [Abstract] [Full Text]  
• Su, B-H, Lin, H-C, Chiu, H-Y, Hsieh, H-Y, Chen, H-H, Tsai, Y-C (2008). Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 93: F94-F99 [Abstract] [Full Text]  
• Jaillard, S., Larrue, B., Rakza, T., Magnenant, E., Warembourg, H., Storme, L. (2006). Consequences of Delayed Surgical Closure of Patent Ductus Arteriosus in Very Premature Infants. Ann. Thorac. Surg. 81: 231-234 [Abstract] [Full Text]  
• Heyman, E., Morag, I., Batash, D., Keidar, R., Baram, S., Berkovitch, M. (2003). Closure of Patent Ductus Arteriosus With Oral Ibuprofen Suspension in Premature Newborns: A Pilot Study. Pediatrics 112: e354-354 [Abstract] [Full Text]  
• Overmeire, B. V., Smets, K., Lecoutere, D., Van de Broek, H., Weyler, J., De Groote, K., Langhendries, J.-P. (2000). A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus. NEJM 343: 674-681 [Abstract] [Full Text]  
• Van Overmeire, B., Follens, I., Hartmann, S., Creten, W. L, Van Acker, K. J (1997). Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child. Fetal Neonatal Ed. 76: 179F-184 [Abstract] [Full Text]  
• McKone, R. C., Weesner, K. M. (1988). Determination of the Time of Closure of the Ductus Arteriosus in Severely III Premature Infants. CLIN PEDIATR 27: 135-139 [Abstract]  
• Kresch, M. J., Moya, F. R., Ascuitto, R. J., Ross-Ascuitto, N. T., Heusser, F. (1988). Late Closure of the Ductus Arteriosus Using Indomethacin in the Preterm Infant. CLIN PEDIATR 27: 140-143 [Abstract]